NH SPAC 2 - Asset Resilience Ratio

Latest as of December 2025: 6.45%

NH SPAC 2 (206640) has an Asset Resilience Ratio of 6.45% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 206640 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩18.17 Billion

≈ $12.31 Million USD Cash + Short-term Investments

Total Assets

₩281.63 Billion

≈ $190.86 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how NH SPAC 2's Asset Resilience Ratio has changed over time. See NH SPAC 2 balance sheet quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down NH SPAC 2's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is NH SPAC 2 worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩18.17 Billion	6.45%
Total Liquid Assets	₩18.17 Billion	6.45%

Asset Resilience Insights

Limited Liquidity: NH SPAC 2 maintains only 6.45% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

NH SPAC 2 Industry Peers by Asset Resilience Ratio

Compare NH SPAC 2's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Medacta Group SA SW:MOVE	Medical Devices	0.86%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	39.15%
Sinocare Inc SHE:300298	Medical Devices	3.53%
Xiangyu Medical Co. Ltd. A SHG:688626	Medical Devices	1.53%
INKON Life Technology Co Ltd SHE:300143	Medical Devices	5.73%
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%

Annual Asset Resilience Ratio for NH SPAC 2 (2015–2025)

The table below shows the annual Asset Resilience Ratio data for NH SPAC 2.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	6.45%	₩18.17 Billion ≈ $12.31 Million	₩281.63 Billion ≈ $190.86 Million	-17.78pp
2024-12-31	24.23%	₩61.71 Billion ≈ $41.82 Million	₩254.67 Billion ≈ $172.59 Million	-9.20pp
2023-12-31	33.43%	₩76.20 Billion ≈ $51.64 Million	₩227.90 Billion ≈ $154.45 Million	+2.54pp
2022-12-31	30.89%	₩60.44 Billion ≈ $40.96 Million	₩195.66 Billion ≈ $132.59 Million	-4.72pp
2021-12-31	35.61%	₩68.45 Billion ≈ $46.39 Million	₩192.24 Billion ≈ $130.28 Million	-0.08pp
2020-12-31	35.68%	₩58.34 Billion ≈ $39.53 Million	₩163.47 Billion ≈ $110.78 Million	+14.27pp
2019-12-31	21.42%	₩21.69 Billion ≈ $14.70 Million	₩101.26 Billion ≈ $68.62 Million	-3.51pp
2018-12-31	24.93%	₩25.79 Billion ≈ $17.47 Million	₩103.44 Billion ≈ $70.10 Million	+1.63pp
2017-12-31	23.30%	₩25.20 Billion ≈ $17.08 Million	₩108.17 Billion ≈ $73.30 Million	+8.25pp
2016-12-31	15.05%	₩13.67 Billion ≈ $9.26 Million	₩90.79 Billion ≈ $61.53 Million	+5.49pp
2015-12-31	9.56%	₩6.86 Billion ≈ $4.65 Million	₩71.71 Billion ≈ $48.59 Million	--

pp = percentage points

About NH SPAC 2

KQ:206640 Korea Medical Devices

Market Cap

$156.06 Million

₩230.28 Billion KRW

Market Cap Rank

#17587 Global

#734 in Korea

Share Price

₩10740.00

Change (1 day)

-1.92%

52-Week Range

₩10120.00 - ₩15090.00

All Time High

₩36222.75